Cargando…

Dopamine and dopamine receptor D1 as a novel favourable biomarker for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most common malignant tumours worldwide. Therefore, the identification and development of sensitivity- genes as novel diagnostic markers and effective therapeutic targets is urgently needed. Dopamine and dopamine receptor D1 (DRD1) are re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhihui, Wen, Peihao, Hu, Bowen, Cao, Shengli, Shi, Xiaoyi, Guo, Wenzhi, Zhang, Shuijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557590/ https://www.ncbi.nlm.nih.gov/pubmed/34717619 http://dx.doi.org/10.1186/s12935-021-02298-9

Ejemplares similares

Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma
por: Guo, Wenzhi, et al.
Publicado: (2017)

Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma
por: Hu, Bowen, et al.
Publicado: (2022)

Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney
por: Liu, Weifeng, et al.
Publicado: (2021)

Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis
por: Yang, Han, et al.
Publicado: (2017)

Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma
por: Yan, Yan, et al.
Publicado: (2020)

High expression of DHX9 promotes the growth and metastasis of hepatocellular carcinoma
por: Shi, Feng, et al.
Publicado: (2021)

The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
por: Bowen, Hu, et al.
Publicado: (2022)

The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets
por: Cheung, Po-Yin, et al.
Publicado: (2001)

Clinical significance of aberrant DEUP1 promoter methylation in hepatocellular carcinoma
por: Yu, Qiwen, et al.
Publicado: (2019)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020)

Dopamine signaling in food addiction: role of dopamine D2 receptors
por: Baik, Ja-Hyun
Publicado: (2013)

Voltage-Dependent Dopamine Potency at D(1)-Like Dopamine Receptors
por: Ågren, Richard, et al.
Publicado: (2020)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors
por: Myslivecek, Jaromir
Publicado: (2022)

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth
por: Yan, Yan, et al.
Publicado: (2022)

Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor
por: Zhuang, Youwen, et al.
Publicado: (2021)

Dopamine D1 Receptor in Cancer
por: Sobczuk, Paweł, et al.
Publicado: (2020)

A Novel Dopamine Receptor Signaling Unit in Brain: Heterooligomers of D1 And D2 Dopamine Receptors
por: George, Susan R., et al.
Publicado: (2007)

Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
por: Berry, Anne S, et al.
Publicado: (2018)

Identification of Context-Specific Fitness Genes Associated With Metabolic Rearrangements for Prognosis and Potential Treatment Targets for Liver Cancer
por: Yu, Shizhe, et al.
Publicado: (2022)

Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis
por: Pan, Xiongfeng, et al.
Publicado: (2019)

Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice
por: Hayashizaki, Seiji, et al.
Publicado: (2013)

The Signaling and Pharmacology of the Dopamine D1 Receptor
por: Jones-Tabah, Jace, et al.
Publicado: (2022)

Microarray Analysis For Expression Profiles of lncRNAs and circRNAs in Rat Liver after Brain-Dead Donor Liver Transplantation
por: Chen, Sanyang, et al.
Publicado: (2019)

Expression of a Novel D4 Dopamine Receptor in the Lamprey Brain. Evolutionary Considerations about Dopamine Receptors
por: Pérez-Fernández, Juan, et al.
Publicado: (2016)

Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
por: Gratz, Michael J, et al.
Publicado: (2018)

Nardosinone Alleviates Parkinson's Disease Symptoms in Mice by Regulating Dopamine D2 Receptor
por: Bian, Li-hua, et al.
Publicado: (2021)

Evidence for D1 Dopamine Receptor Activation by a Paracrine Signal of Dopamine in Tick Salivary Glands
por: Šimo, Ladislav, et al.
Publicado: (2011)

Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine‐induced behavioral sensitization in tree shrews
por: Huang, Jian, et al.
Publicado: (2020)

Dopamine D(4) receptor, but not the ADHD-associated D(4.7) variant, forms functional heteromers with the dopamine D(2S) receptor in the brain
por: González, Sergio, et al.
Publicado: (2011)

Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine
por: Obray, J. Daniel, et al.
Publicado: (2022)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
por: Lin, Zhen, et al.
Publicado: (2021)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

The effects of dopamine and dopamine receptor agonists on the phototransduction cascade of frog rods
por: Nikolaeva, Darya A., et al.
Publicado: (2019)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019)

Fluorescent ligands for dopamine D(2)/D(3) receptors
por: Allikalt, Anni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_coqctk9son4n6htgkpbf74pkhr